Squarepoint’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.03M | Sell |
62,292
-351,229
| -85% | -$24.8M | ﹤0.01% | 1664 |
|
|
2025
Q4 | $27.8M | Buy |
413,521
+55,573
| +16% | +$3.74M | 0.03% | 599 |
|
|
2025
Q3 | $26.3M | Buy |
357,948
+112,920
| +46% | +$7.5M | 0.03% | 620 |
|
|
2025
Q2 | $12.7M | Buy |
+245,028
| New | +$13.9M | 0.01% | 954 |
|
|
2023
Q4 | – | Sell |
-77,945
| Closed | -$2.98M | – | 4194 |
|
|
2023
Q3 | $2.98M | Sell |
77,945
-32,179
| -29% | -$1.32M | 0.01% | 1521 |
|
|
2023
Q2 | $3.97M | Buy |
110,124
+102,848
| +1,414% | +$3.51M | 0.01% | 1215 |
|
|
2023
Q1 | $278K | Sell |
7,276
-154,978
| -96% | -$7.27M | ﹤0.01% | 2620 |
|
|
2022
Q4 | $9.23M | Buy |
162,254
+156,204
| +2,582% | +$8M | 0.04% | 532 |
|
|
2022
Q3 | $239K | Sell |
6,050
-129,703
| -96% | -$5.73M | ﹤0.01% | 2608 |
|
|
2022
Q2 | $5.97M | Buy |
135,753
+112,412
| +482% | +$4.86M | 0.03% | 593 |
|
|
2022
Q1 | $931K | Sell |
23,341
-61,190
| -72% | -$2.18M | ﹤0.01% | 1633 |
|
|
2021
Q4 | $3.4M | Buy |
84,531
+38,789
| +85% | +$1.45M | 0.01% | 963 |
|
|
2021
Q3 | $1.86M | Buy |
+45,742
| New | +$1.91M | 0.01% | 1240 |
|
|
2021
Q2 | – | Sell |
-14,345
| Closed | -$598K | – | 3420 |
|
|
2021
Q1 | $598K | Sell |
14,345
-1,046
| -7% | -$47.8K | ﹤0.01% | 1886 |
|
|
2020
Q4 | $657K | Buy |
+15,391
| New | +$553K | ﹤0.01% | 1606 |
|
|
2020
Q3 | – | Sell |
-68,646
| Closed | -$1.84M | – | 2621 |
|
|
2020
Q2 | $1.84M | Buy |
+68,646
| New | +$1.55M | 0.03% | 661 |
|
|
2020
Q1 | – | Sell |
-92,668
| Closed | -$1.64M | – | 2125 |
|
|
2019
Q4 | $1.64M | Buy |
92,668
+74,870
| +421% | +$1.3M | 0.01% | 1025 |
|
|
2019
Q3 | $276K | Sell |
17,798
-20,715
| -54% | -$341K | ﹤0.01% | 1944 |
|
|
2019
Q2 | $662K | Sell |
38,513
-133,459
| -78% | -$2.15M | 0.01% | 1503 |
|
|
2019
Q1 | $2.77M | Buy |
171,972
+85,674
| +99% | +$1.39M | 0.03% | 639 |
|
|
2018
Q4 | $1.26M | Sell |
86,298
-35,094
| -29% | -$560K | 0.01% | 838 |
|
|
2018
Q3 | $2.21M | Buy |
121,392
+63,892
| +111% | +$1.12M | 0.03% | 687 |
|
|
2018
Q2 | $970K | Buy |
57,500
+34,676
| +152% | +$656K | 0.01% | 903 |
|
|
2018
Q1 | $447K | Sell |
22,824
-43,797
| -66% | -$848K | 0.01% | 1131 |
|
|
2017
Q4 | $1.35M | Buy |
+66,621
| New | +$1.22M | 0.02% | 699 |
|
|
2017
Q3 | – | Sell |
-19,763
| Closed | -$253K | – | 1717 |
|
|
2017
Q2 | $253K | Buy |
+19,763
| New | +$264K | 0.01% | 1210 |
|
|
2016
Q4 | – | Sell |
-12,400
| Closed | -$150K | – | 1827 |
|
|
2016
Q3 | $150K | Buy |
+12,400
| New | +$127K | 0.01% | 927 |
|
|
2016
Q1 | – | Sell |
-35,100
| Closed | -$608K | – | 1281 |
|
|
2015
Q4 | $608K | Buy |
+35,100
| New | +$559K | 0.07% | 439 |
|
|
2015
Q1 | – | Sell |
-13,180
| Closed | -$127K | – | 449 |
|
|
2014
Q4 | $127K | Buy |
+13,180
| New | +$117K | 0.12% | 181 |
|
Other funds holding HALO
VCM
VPM
Squarepoint's HALO Position: Q1 2026 in Review
Squarepoint reduced its Halozyme (HALO) stake by 85% in Q1 2026, selling an estimated $24.8M and leaving 62,292 shares worth $4.03M. The position accounts for ﹤0.01% of the portfolio, ranked #1664.
Squarepoint first reported a position in HALO in Q4 2014 and has held it in 29 quarters since. The position peaked at $27.8M in Q4 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.
- Squarepoint held 62,292 shares of Halozyme worth $4.03M as of Q1 2026.
- Squarepoint sold 351,229 Halozyme shares in Q1 2026, an estimated $24.8M.
- Halozyme made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #1664 holding.
- Squarepoint first reported a position in Halozyme in Q4 2014 and has held it in 29 quarters since.
- Squarepoint's Halozyme position peaked at $27.8M in Q4 2025.
- 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.
Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.